Compare KB & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KB | VEEV |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.3B | 28.7B |
| IPO Year | 2008 | 2013 |
| Metric | KB | VEEV |
|---|---|---|
| Price | $109.25 | $150.37 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 26 |
| Target Price | N/A | ★ $283.80 |
| AVG Volume (30 Days) | 210.9K | ★ 1.6M |
| Earning Date | 04-24-2026 | 05-27-2026 |
| Dividend Yield | ★ 1.46% | N/A |
| EPS Growth | N/A | ★ 25.93 |
| EPS | N/A | ★ 5.44 |
| Revenue | N/A | ★ $1,104,081,000.00 |
| Revenue This Year | $17.53 | $14.42 |
| Revenue Next Year | $3.45 | $12.17 |
| P/E Ratio | ★ $9.90 | $28.88 |
| Revenue Growth | N/A | ★ 28.05 |
| 52 Week Low | $52.91 | $156.23 |
| 52 Week High | $119.71 | $310.50 |
| Indicator | KB | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 63.59 | 22.56 |
| Support Level | $77.84 | N/A |
| Resistance Level | $119.71 | $184.71 |
| Average True Range (ATR) | 2.55 | 6.88 |
| MACD | 1.05 | -2.14 |
| Stochastic Oscillator | 97.06 | 8.33 |
KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.